Post-operative serum procalcitonin vs C reactive Protein as a marker of post-operative infectious complications in pancreatic surgery. A systemic review and metaanalysis.

Aim of Study: Aim of this meta-analysis was to compare diagnostic accuracy of C reactive Protein and Procalcitonin between postoperative day 3 to 5 in predicting infectious complications post pancreatic surgery. Methods: Systemic literature search was performed using MEDLINE, EMBASE and SCOPUS to identify studies evaluating the diagnostic accuracy of Procalcitonin (PCT) and C-Reactive Protein (CRP) as a predictor for detecting infectious complications between postoperative days (POD) 3 to 5 following pancreatic surgery. A meta-analysis was performed using random effect model and pooled predictive parameters. Geometric means were calculated for PCT cut offs. The work has been reported in line with PRISMA guidelines. Results: After applying inclusion and exclusion criteria 15 studies consisting of 2212 patients were included in the final analysis according to PRISMA guidelines. Pooled sensitivity, specificity ,Area under curve and diagnostic odds ratio (DOR)for day 3 C-reactive protein was respectively 62%,67% 0.772 and 6.54.Pooled sensitivity, specificity , Area under curve and diagnostic odds ratio (DOR)for day 3 procalcitonin was respectively 74%,79%,0.8453 and 11.03. Sensitivity, specificity, Area under curve, and Diagnostic odds ratio for day 4 C-reactive protein was respectively 60%,68%, 0.8022 and 11.90. Pooled Sensitivity, specificity and Diagnostic odds ratio of post-operative day 5 procalcitonin level in predicting infectious complications were respectively 83%,70% and 12.9. Pooled Sensitivity, specificity, AUROC and diagnostic odds ratio were respectively 50%,70%, 0.777 and 10.19. Conclusion: Post-operative procalcitonin is better marker to predict post-operative infectious complications after pancreatic surgeries and post-operative day 3 procalcitonin has highest diagnostic accuracy.

Post-operative procalcitonin is better marker to predict post-operative infectious complications after pancreatic surgeries and post-operative day 3 procalcitonin has highest diagnostic accuracy.

Introduction:
Pancreatic surgeries (Pancreaticoduodenectomy/ distal pancreatectomy) are the main treatments for various benign and malignant disease of pancreas, duodenum, and ampullary region. [1]. Pancreatic surgeries are still associated with very high morbidity and mortality.
[2]. Majority of complications following pancreatic surgeries are infectious complications including pancreatic leaks and fistula. [3]. These complications can affect outcomes and also increase cost for pancreatic surgeries. [4].
CRP is not considered as a specific marker for infection, as it can rise in any inflammatory condition. [11].
Procalcitonin is now emerging as a useful and specific marker for sepsis and guide to antibiotic treatment. [12]. It is suggested as a useful marker in predicting infectious complications for colorectal surgeries. [5].
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . https: //doi.org/10.1101//doi.org/10. /2020 However, there is still limited literature comparing effectiveness of C-Reactive Protein and Procalcitonin (PCT) as a marker of infectious complications post pancreatic surgeries and very few studies to show which is better marker to diagnose infectious complications.
Pancreatic surgeries are highly morbid surgeries where early diagnosis of complications can help to reduce mortality.

AIM of the study:
Aim of this meta-analysis was to compare diagnostic accuracy of C reactive Protein and Procalcitonin between postoperative day 3 to 5 in predicting infectious complications post pancreatic surgery.

Materials and Methods: Data collection:
Medline (PubMed), Embase and Scopus were searched with key words like "procalcitonin", "C reactive Protein", "pancreatic surgery", "pancreaticoduodenectomy", "distal pancreatectomy", "post-operative complications", "infective complication", "pancreatic leak", "pancreatic fistula", "anastomotic leak". Studies after Year 2005 (last 15 years) were searched. Anastomotic leak and pancreatic fistula were considered as infectious complications and were included in search strategy. The work has been reported in line with PRISMA (Preferred Reporting Items for Systemic Reviews) and MOOSE (Meta-analysis of observational studies in epidemiology) guidelines. [13,14] Definition of post-operative infectious complications: Infectious complications were defined as any complications like intraabdominal abscess, pancreatic leak, pancreatic fistula, wound complications, urinary tract infection, postoperative pneumonia or adult respiratory distress syndrome. Only clinically significant . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 9, 2020. . https: //doi.org/10.1101//doi.org/10. /2020 pancreatic fistula (ISGPS grade b/c) was considered as an infectious complication. [15] Screening was done by two reviewers (BV and HP) independently at the title, abstract, and full text stages. Any disagreements were discussed between the reviewers before a final decision was made.

Study selection:
Inclusion criteria: • Randomized control trials • Observational cohort study • Studies which included post-operative procalcitonin or C-reactive protein level between postoperative day 3 to 5.
• Studies where subject underwent pancreaticoduodenectomy or distal pancreatectomy • Studies which included patients with age 18 and above.
• Studies which evaluated post-operative complications.

Exclusion criteria:
• Studies where full text articles could not be obtained.
• Studies which included only post-operative day 1,2 or pre-operative procalcitonin or C-reactive protein level.

Data extraction:
Information on study characteristics including patient population, study duration, follow-up period, index test, and reference standard were extracted from each study. The primary outcome, i.e., diagnostic performance of PCT or CRP to detect infectious complications reported as sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative likelihood ratio (LR−) at POD 3 and 5, was collected. As anastomotic leakage or pancreatic fistula were considered a subset of infectious complications and expected to account for most cases of infectious . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 9, 2020. . https: //doi.org/10.1101//doi.org/10. /2020 complications in pancreatic surgery, it was used as the surrogate outcome of interest during data extraction in studies which did not specifically report infectious complications.
Raw data from the articles were used to construct 2*2 tables (true positive, false positive, true negative, and false negative). When unavailable, the tables were constructed using the sensitivity and specificity values provided. For each study, the sensitivity and specificity values mentioned in the article were verified by the reconstruction of the 2*2 contingency table using the data specified in the article.

Risk of bias assessment:
The revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool developed by the Cochrane Collaboration was used to assess for the risk of bias and applicability of each study. [16].
The tool consists of four key domains, i.e., patient selection, index test, reference standard, and patient flow through the study and timing of tests. Two reviewers (BV and HP) assessed the study quality independently. In case of disagreement, the judgment was discussed among themselves before a final decision. publication bias was assessed with the Deeks test. [17].

Statistical analysis:
The statistical analysis was performed according to the Preferred Report Items for Systematic Reviews and Meta-analysis (PRISMA) statement. [13]. The pooled prevalence of infectious complications with corresponding 95% confidence interval (95% CI) was calculated using random effect model. The pooled PCT and CRP cut-off value was derived using geometric mean of the reported PCT and CRP cut-off values. [17]. Using a random effect model, the pooled Se, Sp, LR+, LR−, and diagnostic odds ratios (DOR) with corresponding 95% CI were calculated. Symmetrical summary receiver operating characteristic (SROC) curves were . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020.

RESULTS:
Data extraction, Study characteristics and quality assessment: "PUBMED", "SCOPUS", "EMBASE" database were searched using key words and search  Table 1. The results of the quality assessment using the QUADAS-2 are shown in Figure. 2.
Flaw and timings were unclear in majority of studies.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

REACTIVE PROTEIN AND PROCALCITONIN IN PREDICTING INFECTIOUS COMPLICATIONS POST PANCREATIC SURGERY. [FIGURE 3]
Six studies consisting of 465 patients evaluated post-operative day 3 procalcitonin as a marker of infectious complications and 8 studies consisting of 1745 patients evaluated role of post-operative day 3 C-reactive protein as a marker of post-operative infectious complications.

REACTIVE PROTEIN [FIGURE 4]
Five studies consisting of 907 patients evaluated postoperative day 4 C-reactive protein as marker of infectious complications. Sensitivity, specificity, Area under curve, and Diagnostic odds ratio for day 4 C-reactive protein was respectively 60%,68%, 0.8022 and 11.90.
No studies evaluated day 4 PCT levels.

REACTIVE PROTEIN AND PROCALCITONIN IN PREDICTING INFECTIOUS COMPLICATIONS POST PANCREATIC SURGERY. [FIGURE 5]
Two studies consisting of 111 patients evaluated post-operative day 5 procalcitonin levels.
Pooled Sensitivity, specificity and Diagnostic odds ratio of post-operative day 5 procalcitonin level in predicting infectious complications were respectively 83%,70% and 12.9. SROC could not be constructed as only 2 studies mentioned day 5 procalcitonin levels.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Pooled positive like hood ratios for post-operative day 3 and 5 procalcitonin were respectively 3.17 and 2.91 . Pooled Negative like hood ratios of day 3 and. 5 Procalcitonin were 0.31 and 0.25.

C-reactive protein and Procalcitonin cut off.
Geometric mean PCT cut off for predicting infectious complications at day 3 was 0.80 with 95% C.I. 0.58-1.02. Geometric mean PCT cut off for predicting infectious complications at day 5 was 0.43 with 95% C.I. 0.20-0.65.
Geometric mean CRP cut off for predicting infectious complications at day 3 was 72.2 with 95% C.I. 2-142. Geometric mean CRP cut off for predicting infectious complications at day 4 was 25.3 with 95% C.I. 0-97. Geometric mean CRP cut off for predicting infectious complications at day 5 was 24.8 with 95% C.I. 0-104.
Deek test for publication bias was not significant. (p=0.456)

DISCUSSION:
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. Survival Sepsis Guidelines 2016.
[35] suggests use of PCT as a marker for diagnosing sepsis as well as marker for de-escalation of antibiotics and its use in management of sepsis is gaining popularity now. We decided to use PCT levels at day 3 and day 5 as evidences suggests that PCT can be falsely elevated in first 2 post-operative days. [36,37,38].We found no study that reported day 4 PCT.
CRP is a known inflammatory marker, however CRP levels can rise in multiple inflammatory condition. We here evaluated day 3,4,5 CRP levels for the same reason as in initial post-operative days surgical stress itself can cause elevated CRP levels.
Highest pooled sensitivity , Diagnostic odds ratio, pooled area under curve for CRP in detecting infectious complications were highest on 4 th post-operative day which was respectively 60%, 11.90 and 0.8022. Highest pooled specificity was on 5 th post-operative day, which was 70%.
For procalcitonin pooled sensitivity, specificity, pooled area under curve was on postoperative day 3 which were respectively 74%,79%,0.8453 and 11.03. Pooled sensitivity, specificity and diagnostic odds ratios for day 5 procalcitonin were is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020.  p  r  e  d  i  c  t  i  n  g  p  o  s  t  -o  p  e  r  a  t  i  v  e  i  n  f  e  c  t  i  o  u  s  c  o  m  p  l  i  c  a  t  i  o  n  s  a  f  t  e  r  p  a  n  c  r  e  a  t  i  c  s  u  r  g  e  r  i  e  s  .  P  o  s  t  o  p  e  r  a  t  i  v  e  d  a  y  3  p  r  o  c  a  l  c  i  t  o  n  i  n  i  s  f  o  u  n  d  t  o  b  e  m  o  r  e  a  c  c  u  r  a  t  e  m  a  r  k  e  r  o  f  p  o  s  t  -o  p  e  r  a  t  i  v  e   i  n  f  e  c  t  i  o  u  s  c  o  m  p  l  i  c  a  t  i  o  n  s  a  f  t  e  r  p  a  n  c  r  e  a  t  i  c  s  u  r  g  e  r  Another limitation is majority of studies included pancreaticoduodenectomies only so to confirm these findings in distal pancreatectomies including laparoscopic distal pancreatectomies we need more data.
However, to best of our knowledge this is the only meta-analysis in which an humble attempt is done to compare CRP and PCT as predictive markers for post0operative infectious complications after pancreatic surgeries.
In conclusion, it shows post-operative procalcitonin is better marker to predict post-operative infectious complications after pancreatic surgeries and post-operative day 3 procalcitonin has highest diagnostic accuracy. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . https://doi.org/10.1101/2020  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . https://doi.org/10.1101/2020.10.06.20208181 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020. . https://doi.org/10.1101/2020.10.06.20208181 doi: medRxiv preprint Figure 2: Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 9, 2020.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 9, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 9, 2020. . https://doi.org/10.1101/2020.10.06.20208181 doi: medRxiv preprint